Coronary Angioplasty with Sirolimus Eluting Stents

At present, most percutaneous coronary intervention procedures (PCI) are done with drug eluting stents (DES). However, drug coated balloons (DCB) have shown benefits in restenosis and small vessel de novo lesions. 

Intravascular ultrasound (IVUS) has been shown effective in left main PCI and complex procedures, even though there is little infomration on its use for PCIs with DCB. 

The ULTIMATE III is a clinical randomized controlled open study comparing IVUS guided against angiography guided PCI in patients at high risk of bleeding.

The study included 260 patients with ≤15 mm, 2 to 4 mm in diameter lesions.

Primary end point was late lumen loss (LLL) at 7 months. Patient groups were similar as to demographic and clinical characteristics: mean age 67, 80% were men, 72% were hypertensive, 30% diabetic, 9% had a history of MI, 17% prior PCI, 9% ictus, 5% peptic ulcer, 12% atrial fibrillation, 45% anemia, 10% <100,000 platelet count and 14% kidney function deterioration. 

Read also: Patients with CABG History and new N-ST ACS: Routine Invasive Strategy?

The most frequent clinical presentation was unstable angina (73%), followed by stable chronic angina (14%), and less frequently ST elevation acute myocardial infarction (STEMI), non-ST elevation acute MI (NSTEMI), and silent ischemia. 

There were no differences in lesion localization, the anterior descending being the most affected, followed by the circumflex. Neither were there significant differences in procedure. 

Primary end point resulted favorable for patients receiving IVUS guided PCI (0.03±0.52 mm for ANGIO PCI vs. 0.10±0.34 mm for IVUS PCI; mean difference 0.14 mm; CI 95%: 0.02-0.26; P = 0.025). Also, IVUS PCI was associated with less stenosis (28.15%±13.88% vs. 35.83%±17.69%; P = 0.001) and larger intraluminal diameter (2.06±0.62 mm vs. 1.75±0.63 mm; P < 0.001).

Conclusion

This study has shown IVUS guided PCI is associated with less late lumen loss in patients with de novo coronary lesions vs. angiography guided PCI.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Intravascular Ultrasound vs Angiography- Guided Drug-Coated Balloon Angioplasty. 

Reference: The ULTIMATE III Trial. Xiao-Fei Gao, et al. J Am Coll Cardiol Intv 2024. Article in Press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...